After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Cytek Biosciences Inc. (CTKB) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -0.32%, to $9.35. The Cytek Biosciences Inc. has recorded 39,428 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Cytek® Biosciences Introduces New 20-Color AML Panel.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
Cytek Biosciences Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $9.38 and fluctuated between $10.10 as its day high and $9.38 as its day low. The current market capitalization of Cytek Biosciences Inc. is $1.15B. A total of 0.62 million shares were traded on the day, compared to an average of 682.68K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CTKB has seen 5 BUY and 14 SELL insider trades, representing the acquisition of 13,297 and the disposition of 113,274 shares. Over the last 12 months, there were 28 BUYs and 53 SELLs from insiders. Insiders purchased 1,315,974 shares during that period but sold 513,523.
In the most recent transaction, Jiang Wenbin sold 20,000 shares of CTKB for 10.13 per share on Mar 07. After the transaction, the President and CEO now owns 7,704,439 company shares. In a previous transaction on Feb 21, Yan Ming sold 20,000 shares at 10.94 per share. CTKB shares that Chief Technology Officer owns now total 7,926,053.
Among the insiders who sold shares, Yan Ming disposed of 897 shares on Feb 08 at a per-share price of $13.53. This resulted in the Chief Technology Officer holding 7,944,844 shares of CTKB after the transaction. In another insider transaction, Jiang Wenbin sold 20,000 shares at $13.19 per share on Feb 07. Company shares held by the President and CEO now total 7,720,314.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CTKB in the last 3 months, the mean price target is $15.00 with high estimates of $17.00 and low estimates of $14.00. In terms of 52-week highs and lows, CTKB has a high of $16.05 and a low of $7.38.
As of this writing, CTKB has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.07 per share and a lower estimate of $0.02. The company reported an EPS of $0.03 in the last quarter, which was 50.00% higher than expectations of $0.02.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTKB is Buy with a score of 4.50. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
